Spotlight: Longevity in Context
The latest global trend reports show that fewer consumers are treating health as a reactive category. The demand is shifting toward proactive, preventative, and personalized solutions, spanning everything from wearables and supplements to advanced diagnostics and women’s health platforms.
This shift is not only cultural but also an economic one. According to McKinsey & Company, more than 60% of consumers now consider it “very” or “extremely” important to purchase products and services that support healthy aging and longevity. In the US, UK, and China, up to 85% of consumers report buying more in this category than in previous years across all age groups. Younger generations seek preventive solutions, while older ones aim to extend vitality.
The global supplement market alone is projected to reach $140 billion by 2025. Digital health, telemedicine, AI-driven monitoring tools, and hormonal and metabolic therapies are rapidly scaling, with Gen Z and millennials leading adoption. This growth runs concurrently with consumer expectations for science-backed, evidence-based longevity products.
The industry is not just about consumer products. Reputable clinics, venture funds, research foundations, and infrastructure providers are actively shaping the next layer of the longevity ecosystem. They are seeking strategic partners, scalable solutions, and ways to amplify both clinical and economic outcomes.
And the stakes are high. One McKinsey estimate places the value of adding just one year of healthy life expectancy in the US alone at $38 trillion, with a $6.2 trillion potential GDP uplift across 21 countries due to greater societal participation and delayed age-related decline.
According to InsightAce Analytic, the global market for longevity and anti-senescence therapy stood at $27.1 billion in 2023, with a projected CAGR of 6.8% through 2031. This is just one dimension of the $1.8 trillion global consumer wellness economy, now increasingly oriented toward scientifically credible, long-term health outcomes.
Longevity is no longer a niche. Those who recognize this structural shift early will play the most meaningful roles. The sector is rapidly becoming a convergence point for capital, science, and consumer priorities. For those seeking to engage with funding, clinical services, or long-term societal impact, we can help connect the right people, institutions, and ideas.
Sources
McKinsey: The Trends Defining the $1.8T Global Wellness Market in 2024
McKinsey Health Institute: Healthy Longevity
Vogue: 2025’s hottest trend? Living longer
InsightAce Analytic: Global Longevity and Anti-Senescence Therapy Market Forecast (2023–2031)
The latest global trend reports show that fewer consumers are treating health as a reactive category. The demand is shifting toward proactive, preventative, and personalized solutions, spanning everything from wearables and supplements to advanced diagnostics and women’s health platforms.
This shift is not only cultural but also an economic one. According to McKinsey & Company, more than 60% of consumers now consider it “very” or “extremely” important to purchase products and services that support healthy aging and longevity. In the US, UK, and China, up to 85% of consumers report buying more in this category than in previous years across all age groups. Younger generations seek preventive solutions, while older ones aim to extend vitality.
The global supplement market alone is projected to reach $140 billion by 2025. Digital health, telemedicine, AI-driven monitoring tools, and hormonal and metabolic therapies are rapidly scaling, with Gen Z and millennials leading adoption. This growth runs concurrently with consumer expectations for science-backed, evidence-based longevity products.
The industry is not just about consumer products. Reputable clinics, venture funds, research foundations, and infrastructure providers are actively shaping the next layer of the longevity ecosystem. They are seeking strategic partners, scalable solutions, and ways to amplify both clinical and economic outcomes.
And the stakes are high. One McKinsey estimate places the value of adding just one year of healthy life expectancy in the US alone at $38 trillion, with a $6.2 trillion potential GDP uplift across 21 countries due to greater societal participation and delayed age-related decline.
According to InsightAce Analytic, the global market for longevity and anti-senescence therapy stood at $27.1 billion in 2023, with a projected CAGR of 6.8% through 2031. This is just one dimension of the $1.8 trillion global consumer wellness economy, now increasingly oriented toward scientifically credible, long-term health outcomes.
Longevity is no longer a niche. Those who recognize this structural shift early will play the most meaningful roles. The sector is rapidly becoming a convergence point for capital, science, and consumer priorities. For those seeking to engage with funding, clinical services, or long-term societal impact, we can help connect the right people, institutions, and ideas.
Sources
McKinsey: The Trends Defining the $1.8T Global Wellness Market in 2024
McKinsey Health Institute: Healthy Longevity
Vogue: 2025’s hottest trend? Living longer
InsightAce Analytic: Global Longevity and Anti-Senescence Therapy Market Forecast (2023–2031)